[
    "{\"step_by_step_thinking\": \"Tocilizumab is mentioned in multiple documents as a treatment option for COVID-19. Document [1] mentions a study that was performed to reveal the outcome of COVID-19 patients on tocilizumab. Document [2] discusses a meta-analysis to determine the role of combination therapy with tocilizumab and steroids in COVID-19 patients. Document [4] mentions a systematic review and meta-analysis to estimate the effectiveness of tocilizumab in reduction of mortality due to COVID-19. Therefore, it is clear that tocilizumab has been assessed against Covid-19.\", \"answer_choice\": \"A\"}"
]